Aura Clinic Singapore
Injectable Skincare represents an advanced bio-remodelling injectable technology, designed as the first injectable skincare to address skin laxity and aging signs. It was approved by Health Sciences Authority of Singapore on 17 July 2020 as an injectable treatment to reverse physiological process of skin ageing and reduced hydration by altering the elastic fibers and remodels the collagen in the dermis.
Notably, Injectable Skincare stands out as the sole hyaluronic acid (HA) injectable capable of enhancing skin laxity by stimulating elastin production. Boasting one of the highest HA concentrations on the market (64mg / 2ml), it provides a powerful boost to skin hydration levels.
The breakthrough NAHYCO® Technology is instrumental in achieving this, bringing together 32mg of high molecular HA (H-HA) and 32mg of low molecular HA (L-HA). These components undergo thermal cross-linking, forming the unique Hybrid Cooperative Complex Hyaluronic (HCC) Acid. Beyond its exceptional hydrating properties, HCC Acid actively stimulates collagen and elastin, promoting the remodeling of sagging tissue for visibly firmer and more youthful-looking skin.
Note: Please note that the Ministry of Health of Singapore prohibits the publication of before-and-after photos and patient testimonials in advertising materials. To learn more about this treatment, visit our clinics, where we can provide additional photographs and patient images.